Part of the ICU Specialty Career Hub — browse every related guide in one place.
Oncology nursing attracts nurses who find meaning in longitudinal patient relationships, can hold both hope and grief simultaneously, and want the clinical depth of managing complex treatment regimens and disease processes. It's a specialty with remarkable variation — the oncology nurse in a community cancer center has a fundamentally different day than the oncology nurse on an inpatient hematology floor at an NCI-designated comprehensive cancer center. Understanding this variation is the starting point for any honest career analysis.
| Setting | Typical Salary Range | Notes |
|---|---|---|
| Outpatient infusion / cancer center | $62,000–$90,000/year | M–F schedule, predictable hours, no call; lower pay than inpatient oncology in most markets |
| Inpatient oncology / heme-onc | $68,000–$100,000/year | Higher acuity, rotating shifts, more complex care; better pay than outpatient at most facilities |
| Bone marrow transplant (BMT) unit | $72,000–$108,000/year | Highest acuity in oncology nursing; immunocompromised patients post-transplant; complex management |
| California (union, inpatient onc) | $90,000–$130,000/year | CNA contract rates; major academic cancer centers pay at top of scale |
| Oncology travel nursing | $2,000–$3,500/week all-in | Less travel availability than adult ICU; inpatient heme/onc most in demand |
Chemotherapy administration: The signature skill of oncology nursing is safe chemotherapy preparation verification and administration. Oncology nurses must know vesicant vs. irritant vs. non-vesicant drugs and the clinical consequences of extravasation. Anthracyclines (doxorubicin), taxanes (paclitaxel), vinca alkaloids (vincristine), and platinum agents (cisplatin) have distinct toxicity profiles and administration requirements that oncology nurses manage.
Chemotherapy administration certification (typically through ONS — the Oncology Nursing Society) is required or strongly preferred at most facilities before nurses independently administer chemotherapy. ONS's Chemotherapy and Biotherapy Provider Card is the standard credential.
Immunotherapy management: Immune checkpoint inhibitors (pembrolizumab, nivolumab, ipilimumab) and CAR-T cell therapies have transformed oncology practice and added new complexity to oncology nursing. Immune-related adverse events (irAEs) — including immune-mediated colitis, pneumonitis, and endocrinopathies — require oncology nurses to recognize toxicities that can occur weeks after infusion. CAR-T nursing (increasingly common at specialized centers) requires additional training in cytokine release syndrome (CRS) and neurotoxicity management.
Port access: Most outpatient oncology patients have implanted venous access devices (ports). Oncology nurses access ports for every infusion cycle — a procedural skill that becomes routine but requires sterile technique and attention to signs of port failure or infection.
Symptom management: Nausea and vomiting prevention and treatment, mucositis management, neutropenic fever recognition and response, pain management in cancer patients, fatigue management, and peripheral neuropathy monitoring are all core oncology nursing practice areas. Oncology nurses develop sophisticated pharmacological knowledge in supportive care.
Bone marrow transplant nursing (BMT-specific): BMT nurses manage patients receiving conditioning regimens (high-dose chemotherapy and/or total body irradiation) that ablate the immune system before stem cell infusion. The post-transplant engraftment period involves profound immunosuppression, graft-versus-host disease (GVHD) risk, infectious complications, and organ toxicity. BMT nursing requires knowledge of immunology, transplant pharmacology, and comfort with managing critically ill patients in an oncology context.
The most significant career decision in oncology nursing is the outpatient-inpatient split. The two environments are genuinely different practices:
Outpatient infusion nursing: Patient populations are predominantly ambulatory, receiving scheduled treatments over weeks to months. The nursing relationship is longitudinal — nurses often know their patients over years. Hours are predictable (most outpatient cancer centers are M–F, 8–5 or similar). The technical focus is infusion management, treatment toxicity monitoring, and patient education. The acuity of individual patients can escalate rapidly — a patient who presents for a routine infusion can develop anaphylaxis or cardiovascular toxicity — but the baseline setting is less acute than inpatient.
Inpatient heme/onc nursing: Sicker patient population (patients sick enough to require hospitalization for treatment or complication management), rotating shifts, higher nursing-to-patient ratios, and more complex concurrent care management. Inpatient oncology nurses manage febrile neutropenia protocols, transfusion therapy, high-dose chemotherapy toxicity, tumor lysis syndrome, and end-of-life care on the same unit in the same shift.
The OCN (Oncology Certified Nurse) is offered by the Oncology Nursing Certification Corporation (ONCC). Eligibility requires: current RN licensure, 1 year of RN experience within the previous 3 years, and 1,000 hours of oncology nursing practice within the previous 2.5 years.
OCN is the baseline oncology nursing credential and is widely recognized. Additional ONCC certifications for specialized practice areas include:
BMTCN (Blood and Marrow Transplant Certified Nurse) — for BMT nurses. CBCN (Certified Breast Care Nurse) — for breast oncology specialists. AOCNP (Advanced Oncology Certified Nurse Practitioner) — for APRNs in oncology. AOCNS (Advanced Oncology Certified Clinical Nurse Specialist) — CNS designation for oncology.
For most staff oncology nurses, OCN is the target certification. Certification differentials are $1–3/hour at most facilities. OCN also strengthens applications for senior, charge, and coordination roles in oncology departments.
Oncology nurses develop longitudinal relationships with patients in a way that differs from most acute care specialties. A patient treated for breast cancer over 6 months of chemotherapy is known — their family, their fears, their good days and bad days. When that patient's disease progresses or they die, the oncology nurse loses someone they've genuinely come to know.
This relationship depth is why oncology nursing is profoundly meaningful to nurses who choose it — and also why oncology has high rates of compassion fatigue and secondary traumatic stress when nurses don't have adequate support systems. Research consistently shows that oncology nurses who receive peer debriefing, have adequate staffing ratios, and work in cultures that acknowledge the grief of patient loss sustain careers longer than those who don't.
The question nurses should ask before entering oncology: "Can I hold grief and hope simultaneously, over years, without burning out?" Nurses who answer yes and have the self-awareness to maintain that equilibrium do well in oncology long-term.
Oncology nursing — whether outpatient infusion or inpatient heme/onc — does not count as ICU experience for CRNA school admission. CRNA programs require critical care ICU experience, which refers to adult intensive care units managing hemodynamically unstable patients on mechanical ventilation, vasopressors, and invasive monitoring. Oncology nursing, even at the BMT level, is not equivalent to this clinical environment.
Oncology nurses who want to pursue CRNA need to transition to adult ICU and build critical care hours there. The clinical knowledge from oncology — pharmacological depth, IV access expertise, patient advocacy skills — is genuinely valuable in CRNA training, but it does not substitute for ICU hours. See the ICU to CRNA timeline for the transition pathway.
Related guides: ICU nurse salary | Clinical ladder
Get the ICU Notebook
Free investing strategies built for nurses. One email per week, no fluff.
Yes, send it freeNo spam. Unsubscribe any time.